Patrys (ASX:PAB) has taken significant steps toward advancing a potential new treatment for delirium into human clinical trials, including manufacturing and regulatory preparations for its experimental drug candidate RLS-2201. …
Patrys moves toward first human trial for injectable delirium therapy
March 12, 2026 Australian Biotech
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 24 April
April 24, 2026 - - Podcast -
Prevention warning as Pfizer urges Budget reset on vaccines and immunisation
April 24, 2026 - -
NDIS fraud is so extensive that 'prosecuting our way out of it' is now impractical
April 24, 2026 - - Latest News -
Boehringer Ingelheim and Heart of Australia take mobile lung care deeper into regional Australia
April 24, 2026 - - Latest News -
A decade to diagnosis highlights hidden burden of immune disorders
April 24, 2026 - - Latest News -
Quiet diplomacy as Australia navigates global pricing pressure, but can it work?
April 24, 2026 - - Latest News -
New immunotherapy option approved for Australians with relapsed follicular lymphoma
April 24, 2026 - - Latest News